BHCM
LUNG icon

Brevan Howard Capital Management’s Pulmonx LUNG Stock Holding History

Brevan Howard Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,238
Closed -$103K – 1938
2025
Q1 		$103K Buy
+15,238
New +$108K ﹤0.01% 1050

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brevan Howard Capital Management's LUNG Position: Q2 2025 in Review

Brevan Howard Capital Management sold out of Pulmonx (LUNG) in Q2 2025, closing a stake of 15,238 shares — an estimated $103K sold.

Brevan Howard Capital Management first reported a position in LUNG in Q1 2025 and held it in 1 quarter. The position peaked at $103K in Q1 2025. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2025.

  • Brevan Howard Capital Management reported no remaining Pulmonx position as of Q2 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 15,238 Pulmonx shares in Q2 2025, an estimated $103K.
  • Brevan Howard Capital Management first reported a position in Pulmonx in Q1 2025 and held it in 1 quarter.
  • Brevan Howard Capital Management's Pulmonx position peaked at $103K in Q1 2025.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2025.

Based on Brevan Howard Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.